Physician profile
Aloha Hand
NPI 1780131235
$2,630.71
in general payments reported to CMS, 2019-2025
19 companies · $173 in 2025
The $173 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $189 · 2022: $362 · 2023: $1,757 · 2024: $149 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,001 · Travel and Lodging: $906 · Education: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.19 |
| Travel and Lodging | $906.36 |
| Education | $171.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $1,336.10 | 2023 | Axonics |
| Astellas Pharma US INC | $307.14 | 2022-2023 | Myrbetriq |
| Astrazeneca Pharmaceuticals LP | $121.04 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Mylan Specialty L.P. | $117.17 | 2021-2024 | Yupelri |
| Abbvie INC. | $114.88 | 2021-2024 | |
| Lilly USA, LLC | $98.84 | 2021-2025 | Zepbound, Jardiance |
| Myriad Women'S Health, INC. | $84.86 | 2023 | Myrisk |
| Novo Nordisk INC | $70.63 | 2021-2025 | Rybelsus, Ozempic |
| Pfizer INC. | $66.68 | 2021-2023 | |
| Ultragenyx Pharmaceutical INC. | $63.69 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $50.42 | 2022 | |
| Viatris Specialty LLC | $41.15 | 2025 | Yupelri |
| Xeris Pharmaceuticals, INC. | $38.03 | 2023 | Gvoke Hypopen |
| E.R. Squibb & Sons, L.L.C. | $34.89 | 2021 | |
| Amgen INC. | $20.65 | 2024 | Otezla, Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $17.84 | 2025 | Tirosint, Flector, Licart |
| Dexcom, INC. | $17.01 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.36 | 2022 | |
| Medtronic, INC. | $13.33 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aloha Hand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.